A Nicolau Syndrome Confused with Cellulite
Academic Journal of Health · 2023
DOI: 10.14744/ajh.2023.32042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Journal of Health, 2023. Verfasst von Tuğba Atak.
Abstract (Originalsprache)
Nicolau syndrome, also known as embolia cutis medicamentosa or livedoid dermatitis, emerges as a rare complication following intramuscular, subcutaneous, or intraarticular injections.This condition may result in severe pain, erythematous lesions, livedoid and hemorrhagic plaques, as well as necrosis affecting the skin, fat, and muscle layers post-injection.Notable causative agents encompass non-steroidal anti-inflammatory drugs (NSAIDs), etanercept, and antibacterial agents.While there›s no definitive cure for Nicolau syndrome, available treatment options range from wound care, bed rest, and pain management to antibiotics for secondary infections, topical, intralesional, and systemic corticosteroids.Moreover, vasoactive agents like alprostadil and pentoxifylline, anticoagulants, and hyperbaric oxygen therapy can be utilized.In severe cases marked by necrosis, surgical interventions become imperative.This report presents a case where a female patient developed Nicolau syndrome following a diclofenac sodium injectio.
Zitieren
APA
Atak, T. (2023). A Nicolau Syndrome Confused with Cellulite. Academic Journal of Health. https://doi.org/10.14744/ajh.2023.32042
Vancouver
Atak T. A Nicolau Syndrome Confused with Cellulite. Academic Journal of Health. 2023. doi:10.14744/ajh.2023.32042
BibTeX
@article{Atak2023,
author = {Atak, Tuğba},
title = {A Nicolau Syndrome Confused with Cellulite},
journal = {Academic Journal of Health},
year = {2023},
doi = {10.14744/ajh.2023.32042}
}
EUVIMED